Home » Archive by Category


Supplier Quality Engineer – Medical Device (San Diego, CA)

November 25, 2014 – 11:18 am | Edit Post

Bachelor’s Degree in Engineering Field.
Experience in maintaining and designing the supplier quality management system, supplier selection, qualification, and approval, supplier qualification audits, monitor supplier performance, pr [...]

Supplier Quality Engineer – Medical Device (San Diego, CA)

November 25, 2014 – 11:18 am | Edit Post

Bachelor’s Degree in Engineering Field.
Experience in maintaining and designing the supplier quality management system, supplier selection, qualification, and approval, supplier qualification audits, monitor supplier performance, pr [...]

RA Scientist EP Trainer (Wateridge Circle)

November 25, 2014 – 11:17 am | Edit Post

Title: Research Associate/Research Scientist
Department(s): Research & Development
Reports to: R&D Lab Coordinator
Employee Type: Full-time
Location: San Diego, CA
Company Profile
Inovio is revolutionizing the fight against cancer and infectiou [...]

Query genes beyond species, at levels of genus, family,…,phylum

November 25, 2014 – 11:06 am | Edit Post

In a typical MyGene.info query, you can query genes for one or multiple species by providing a “species” parameter:



MyGene.info now allows you to query genes at the level beyond species, that is, you can now query for matching genes for any given genus, family, or even phylum from the taxonomy tree (effectively any node from the tree). For example, you can now query for “lytic enzyme” in any firmicutes (gram-positive bacteria, taxonomy id: 1239):

http://mygene.info/v2/query?q=lytic enzyme&species=1239&include_tax_tree=true

or, in Python:

mg = mygene.MyGeneInfo()
mg.query(‘lytic enzyme’, species=1239, include_tax_tree=True)

Note that include_tax_tree=true parameter toggles the query against all taxonomy ids under 1239 node in the taxonomy tree (including 1239 itself). As comparison, the query without this parameter:

http://mygene.info/v2/query?q=lytic enzyme&species=1239

will return empty hits, as no genes are annotated at the level of firmicutes.

We expect this new feature will be particularly useful for the fields like evolutionary biology and microbiome. In fact, this was a requested feature from our users in those fields. So, please give a try and let us know your feedback.

The exact usage of this feature is summarized below:

species parameter accepts one or multiple taxnomony ids (multiple ids separated by commas)
passing include_tax_tree=true expands the query against any sub-nodes of passed taxids (from species parameter) in the taxonomy tree, including the taxids themselves.
Since you can pass any taxonomy id from the taxonomy tree, we will cap the expanded taxonomy id list to 10,000, so that it won’t overload our servers.


This feature is made possible through the project led by Greg Stupp at recent 2nd NoB Hackathon.

Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference

November 25, 2014 – 11:00 am | Edit Post

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at two investor conferences next week.

On December 2 at 11:40am Eastern Time (8:40am Pacific Time) he will make a presentation at the 2014 Deutsche Bank BioFEST in Boston. 

On December 3 at 12:00pm Eastern Time (9:00am Pacific Time) he will make a presentation at the 26th Annual Piper Jaffray Healthcare Conference in New York City.

Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company’s two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women’s health that is partnered with AbbVie Inc., and a wholly owned vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the internet at http://www.neurocrine.com.
SOURCE Neurocrine Biosciences, Inc.

Pharamceutical Facilities Engineer (San Diego, CA)

November 25, 2014 – 10:39 am | Edit Post

Facilities Engineer-
Bachelor’s Degree in an Engineering discipline.
GMP Manufacturing experience required (5-10 years).
Experience with BMS systems, troubleshooting and upgrades, approved, installed, commissioned and validated.

goBalto Selected as a 2014 Red Herring Top 100 Global Company

November 25, 2014 – 10:39 am | Edit Post

SAN FRANCISCO, Nov. 25, 2014 /PRNewswire/ – goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, has been recognized as a winner of Red Herring’s Top 100 Global award. goBalto also received a Global Top 100 North America award in 2013, marking its emergence as a top player in the international technology landscape.

Red Herring’s Top 100 Global list has become a mark of distinction for identifying promising new companies and entrepreneurs. Red Herring editors were among the first to recognize that companies such as Facebook, Twitter, Google, Yahoo, Skype, Salesforce.com, YouTube, and eBay would change the way we live and work. 

“Choosing the companies with the strongest potential was by no means a small feat,” said Alex Vieux, publisher and CEO of Red Herring. “After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across the globe to the Top 100 winners. We believe goBalto embodies the vision, drive and innovation that define a successful entrepreneurial venture. goBalto should be proud of its accomplishment.”

Red Herring’s editorial staff evaluated the companies on both quantitative and qualitative criteria, such as financial performance, technology innovation, management quality, strategy, and market penetration. This assessment of potential is complemented by a review of the track records and standing of startups relative to their peers, allowing Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models from around the world.

“We’re deeply honored to be recognized once again by Red Herring as a game-changing and life-changing company, and for being the only clinical solution to receive the award” said Sujay Jadhav, goBalto CEO. “We have a growing roster of global customers who are reaping the benefits of our solutions, to make their clinical study startup process shorter, more transparent, and much more efficient. I’m proud that we’re using technology to literally ‘change the way we live and work’. Anyone with a loved one whose life has been prolonged or saved by a drug or medical device understands how important it is to shorten the clinical trials process. Red Herring’s acknowledgment of our work demonstrates to a wide audience that this is exactly what we’re successfully doing.”

The Red Herring 2014 Top 100 Global winners were announced at the Red Herring Global 2014 forum in Los Angeles on November 18-20, 2014.

About goBalto

goBalto develops next-generation solutions that simplify and accelerate clinical study startup in the pharmaceutical, biotechnology, and medical device industries. Our management team has over 100 years of combined experience in the life sciences industry and enterprise software implementation. Our team has worked for such companies as Amgen, Genentech, Quintiles, Roche, Johnson & Johnson, and Model N. With a proven commitment to customer success, disruption, and study startup optimization, we’re changing the way our leading global pharma and CRO customers approach their business processes. Based in San Francisco, California, we have satellite offices in Pennsylvania and Singapore. For more information, visit www.gobalto.com.

Press contacts:Maria Breaux415.671.4372mbreaux@gobalto.com

Amanda JonesConnect Marketing801-373-7888amandaj@connectmarketing.com

Logo – http://photos.prnewswire.com/prnh/20141118/159334LOGO

SOURCE goBalto, Inc.

Business Development Executive, Market Access – East & West – Covance – San Diego, CA

November 25, 2014 – 10:24 am | Edit Post

Provides weekly sales activity reports to management. Uses SFDC to manage internal communication and document territory and client information as required for…
From Covance – 25 Nov 2014 17:24:56 GMT
– View all San Diego jobs

Production Scientist I (3rd Shift) – Lab Support – San Diego, CA

November 25, 2014 – 10:14 am | Edit Post

AMAZING opportunity to join a Biotechnology company who is major force in advancing biotechnology research located in Sorrento Valley….
From Lab Support – 25 Nov 2014 17:14:09 GMT
– View all San Diego jobs

Vegetable Oil Ingredient Key to Destroying Gastric Disease Bacteria

November 25, 2014 – 10:03 am | Edit Post

The bacterium Helicobacter pylori is strongly associated with gastric ulcers and cancer. To combat the infection, researchers at University of California, San Diego School of Medicine and Jacobs School of Engineering developed LipoLLA, a therapeutic nanoparticle that contains linolenic acid, a component in vegetable oils.